newsfilter
← Latest News
GlobeNewswire·

Vaxxinity to Present at Upcoming March Scientific and Medical Conferences

CAPE CANAVERAL, Fla., March 02, 2023 (GLOBE NEWSWIRE) -- Vaxxinity, Inc. (NASDAQ:VAXX), a U.S. company pioneering the development of a new class of immunotherapeutic vaccines, today announced that its scientists and